Pilot Study: Biomarker Directed Treatment in Metastatic Colorectal Cancer
Latest Information Update: 12 May 2022
At a glance
- Drugs Cetuximab (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Colorectal cancer
- Focus Biomarker; Therapeutic Use
- Acronyms AMGT-ERCC1
- 09 Sep 2020 Status changed from active, no longer recruiting to completed.
- 06 Jan 2020 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.
- 06 Jan 2020 Planned primary completion date changed from 1 Aug 2019 to 1 Dec 2020.